Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2004

Rh(D) Incompatibility: Screening in Unsensitized Rh(D)-Negative Pregnant Women

Description of Resource: 
The U.S. Preventive Services Task Force (USPSTF) recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks of gestation, unless the biological father is known to be Rh(D)-negative. This is a B recommendation, which means the USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
U.S. Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Maternal, Infant, and Child Health
Resource Type: 
Systematic Review
Citation: 
U.S. Preventive Services Task Force. Rh(D) Incompatibility: Screening [Internet]. 2004 Feb [cited 2017 Sept 8]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/rh-d-incompatibility-screening?ds=1&s=Rh(D)%20Incompatibility